The rise of minimally invasive and robotic-assisted surgery serves as a primary catalyst for this growth. Hospitals are increasingly prioritizing high-precision tools, leading to the widespread adoption of near-infrared fluorescence imaging. Technologies such as Stryker’s 1688 AIM 4K Platform and Intuitive Surgical’s da Vinci system with Firefly integration allow clinicians to visualize blood flow, lymphatic structures, and tissue perfusion in real time. This capability has become a competitive necessity in specialties ranging from oncology and urology to hepatobiliary procedures.
Global Indocyanine Green Market Projected to Reach $380 Million by 2031
The global indocyanine green market is set for significant expansion, with valuations expected to climb from $180 million in 2025 to $380 million by 2031. Driven by a compound annual growth rate of 13.26%, the sector is benefiting from the rapid integration of fluorescence imaging into modern surgical and diagnostic workflows.
Beyond the operating room, ophthalmic angiography remains a cornerstone of the market. As the prevalence of retinal conditions like age-related macular degeneration and diabetic retinopathy increases, demand for high-resolution diagnostic imaging continues to climb. North America currently leads this technological shift, commanding roughly 37% of the global market share in 2025. With specialty clinics emerging as the fastest-growing end-user segment, the industry is poised for sustained development through at least 2031.
Comments (0)
No comments yet. Be the first!